The antioxidant requirements for implantable polymer materials are extremely strict, ensuring that the material does not age during sterilization and long-term use, while not affecting biocompatibility. The new generation of medical antioxidants is designed with precise molecular structure, covalently linking antioxidant groups with polyethylene glycol fragments, which not only improves their dispersibility in the polymer matrix, but also endows the material surface with anti protein adsorption properties. Animal experiments have shown that after 6 months of implantation of vascular stents containing such antioxidants, the degree of intimal hyperplasia is reduced by 35% compared to traditional materials.
The antioxidant protection of biodegradable biomaterials is more complex. The acidic environment generated during the degradation process of polylactic acid materials accelerates oxidation, and traditional antioxidants are often incompatible with the degradation products. The latest solution is to use natural antioxidant derivatives, such as quercetin polylactic acid copolymers, which not only act as antioxidants in the material but also participate in the polymer chain structure, achieving precise matching between degradation rate and antioxidant requirements. Preclinical studies have shown that this intelligent antioxidant system prolongs the strength retention time of absorbable sutures by 50%.
The antioxidant requirements of drug delivery systems are often overlooked. Liposomes and other nanocarriers are prone to phospholipid oxidation during storage and in vivo delivery, leading to drug leakage and increased toxicity. By directly embedding vitamin E analogs into phospholipid bilayers, researchers have developed a "self antioxidant" carrier system. This design not only protects the integrity of the carrier, but its oxidation products can also act as signaling molecules to trigger targeted release at the tumor site, achieving synergistic enhancement of antioxidant and intelligent drug delivery.
